Ultrasound images that can predict the risk of stroke in asymptomatic patients 

Original title: Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS). Reference: Stavros K. Kakkos et al. J Vasc Surg 2013;57:609-18.

Despite multiple studies for a uniform approach to treat asymptomatic carotid lesions, it has not been achieved. Many factors have been proposed that contribute to the stratification including the severity of the stenosis, the plaque type, clinical, silent myocardial tomography, etc. A hypoechoic area close to the lumen of the artery corresponds with the histological finding of a vulnerable lipid core. 

The objective of this study was to test the hypothesis that the presence and size of hypoechoic areas close to the lumen could predict future ipsilateral ischemic events in asymptomatic patients. The study included 1,121 patients, followed by Doppler and clinically, every six months for a period of up to eight years, (mean 4 years). During follow-up there were 130 ipsilateral ischemic events in the population of which 59 were strokes, (12 of them fatal), 49 transient ischemic attacks and 22 amaurosis fugax. 

The average annual risk of events correlated linearly with the presence and size of hypoechoic areas near the vessel lumen diagnosed by ultrasound. Patients with hypoechoic areas

Conclusion: 

The size of the hypoechoic area near the lumen has a linear relationship with the risk of stroke and can be used to stratify asymptomatic patients. The results should be confirmed in future studies because they may change decisions for asymptomatic patients in which, historically, only the percentage of stenosis was used.

Commentary: 

The percentage of stenosis has a poor correlation with hypoechoic areas near the lumen vessel, (Pearson coefficient r = 0.083), which gives even more importance to this new setting. In fact, a hypoechoic area being used to discriminate asymptomatic patients is better for those with less severe injuries. 

SOLACI.ORG

More articles by this author

New Carotid PCI All-in-One System

Carotid stenting is equivalent to carotid endarterectomy in terms of major adverse events (death, AMI, and stroke). However, it entails higher risk of minor...

PERFORMANCE II Trial: Safety and Efficacy of the New NeuroGuard Carotid Stent System

The percutaneous treatment of carotid artery disease through stenting (CAS) for the prevention of cerebrovascular disease has proven to be an effective alternative compared...

Carotid Endarterectomy vs. Carotid Angioplasty in Symptomatic and Asymptomatic Patients: 30-Day Outcomes

Extracranial carotid artery disease represents 15 to 20% of all strokes. Carotid revascularization plays a role in primary and secondary prevention of cerebrovascular events....

Mild or Intermediate Symptomatic Carotid Lesions: What we need to know about plaque

Ischemic stroke is the main reason behind disability in the world, and it is often followed by death.  The rupture of carotid atherosclerotic plaque and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...